People: IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

135.20USD
24 Oct 2014
Price Change (% chg)

$8.85 (+7.00%)
Prev Close
$126.35
Open
$133.00
Day's High
$140.00
Day's Low
$132.98
Volume
464,870
Avg. Vol
184,741
52-wk High
$140.00
52-wk Low
$101.36

Search Stocks

Powers, Johnny 

Brief Biography

Dr. Johnny D. Powers, Ph.D., is Executive Vice President of IDEXX Laboratories, Inc., since July 20, 2012. He overseeing IDEXX Reference Laboratories, Telemedicine, Rapid Assay, Bioresearch and Worldwide Operations. He joined IDEXX as Corporate Vice President in February 2009, leading the Company’s worldwide reference laboratories business. Prior to joining the Company, Dr. Powers was Vice President responsible for the Cancer Diagnostics business of Becton, Dickinson and Company, a medical technology company, from 2007 to 2008. Dr. Powers joined Becton, Dickinson and Company as a result of its acquisition in 2006 of TriPath Imaging Inc., a molecular diagnostics-based cancer diagnostics company, where he held various positions from 2001 to 2007, including Vice President of Worldwide Operations, and most recently served as President of the TriPath Oncology business unit. From 1996 to 2001, Dr. Powers was employed by Ventana Medical Systems, Inc., a tissue-based cancer diagnostics company, where he held various positions, including Vice President and General Manager of the Anatomical Pathology business and Vice President and General Manager of Worldwide Operations. From 1989 to 1996, Dr. Powers was employed by Organon Teknika Corporation, a medical diagnostics company, in various technical management roles. Dr. Powers holds a bachelor’s degree in chemistry from Wake Forest University, an M.S. in chemical engineering from Clemson University, an M.B.A. from the Duke University Fuqua School of Business and a Ph.D. in biochemical engineering from North Carolina State University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
396,154 -- 1,463,760 2,234,880

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 5,000 314,861.00
Name Fiscal Year Total

Jonathan Ayers

3,973,980

Brian McKeon

--

Jay Mazelsky

2,232,920

Johnny Powers

2,234,880

Michael Williams

2,781,760

Jacqueline Studer

--
As Of 30 Dec 2013
Search Stocks